MedPath

Formulation of a topical gel containing Lawsonia inermis and Aloe vera and evaluation its effects on radiation-induced dermatitis

Phase 3
Recruiting
Conditions
Dermatitis.
Dermatitis, unspecified
L30.9
Registration Number
IRCT20191106045356N7
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
56
Inclusion Criteria

Patients starting radiotherapy
Patients aged 18 to 65 years

Exclusion Criteria

Patients with skin diseases
Allergy to henna or aloe vera
use the medicine for two consecutive days
Severe systemic diseases such as uncontrolled diabetes, epilepsy, immune system defects, etc.
Occurrence of local infection and swelling and redness at the site of dermatitis
Incidence of dermatitis and the need for medical treatment of the patient

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath